VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $29,144,000 | +674.9% | 1,064,435 | +1026.4% | 2.12% | +4402.1% |
| Q1 2022 | $3,761,000 | +30.5% | 94,499 | +5.0% | 0.05% | -75.3% |
| Q4 2021 | $2,882,000 | +17.3% | 89,967 | +8.0% | 0.19% | +11.8% |
| Q3 2021 | $2,456,000 | -11.7% | 83,331 | +1.9% | 0.17% | -12.8% |
| Q2 2021 | $2,780,000 | -0.3% | 81,812 | -4.6% | 0.20% | -8.9% |
| Q1 2021 | $2,787,000 | +13.6% | 85,753 | +25.9% | 0.21% | +6.5% |
| Q4 2020 | $2,453,000 | -11.2% | 68,103 | -3.5% | 0.20% | -20.6% |
| Q3 2020 | $2,762,000 | -90.0% | 70,542 | -90.6% | 0.25% | -90.0% |
| Q2 2020 | $27,583,000 | +60.0% | 751,987 | +0.5% | 2.53% | -10.0% |
| Q1 2020 | $17,243,000 | +121.3% | 748,379 | +181.2% | 2.81% | +125.3% |
| Q4 2019 | $7,791,000 | +1707.7% | 266,093 | +1550.4% | 1.25% | +1851.6% |
| Q3 2019 | $431,000 | – | 16,123 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |